Related Experiment Video
Updated: Mar 6, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Study of Serum Uric Acid Levels in Myocardial Infarction and Its Association With Killip Class
Maryam Mehrpooya1, Farnoosh Larti1, Younes Nozari2
1Department of Cardiology, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
Insights
Elevated uric acid levels are linked to heart failure, particularly in ST-elevation myocardial infarction (STEMI) patients. Higher uric acid correlates with worse clinical status and disease severity in these individuals.
Area of Science:
- Cardiology
- Biochemistry
- Internal Medicine
Background:
- Heart failure (HF) is a complex clinical syndrome with significant morbidity and mortality.
- Uric acid, a product of purine metabolism, has been implicated as a potential biomarker in cardiovascular diseases.
- The relationship between uric acid levels and the severity of heart failure, especially in acute settings like STEMI, requires further elucidation.
Purpose of the Study:
- To compare serum uric acid levels between patients with and without heart failure.
- To investigate the association between uric acid levels and the clinical status (Killip class) in patients with ST-elevation myocardial infarction (STEMI).
- To explore the correlation of uric acid with left ventricular (LV) systolic dysfunction and treatment strategies in STEMI.
Main Methods:
- A case-control study involving 50 patients with acute heart failure and 50 controls.
- Echocardiography was used for clinical assessment and documentation of heart failure.
- Serum uric acid levels were measured and compared across different patient groups and clinical classifications.
Main Results:
- Patients with heart failure exhibited significantly higher mean serum uric acid levels (7.6 mg/dL) compared to controls (4.5 mg/dL).
- In STEMI patients, uric acid levels were markedly elevated (9.2 mg/dL) compared to non-STEMI heart failure patients (6.5 mg/dL).
- Uric acid levels showed a significant positive correlation with Killip class, severity of LV systolic dysfunction, and were higher in STEMI patients requiring CABG versus PCI.
Conclusions:
- Serum uric acid is significantly elevated in patients with heart failure, including those with STEMI.
- Higher uric acid levels are associated with poorer clinical status (higher Killip class) and more severe LV systolic dysfunction in STEMI patients.
- Uric acid may serve as a valuable biomarker for assessing disease severity and guiding treatment decisions in acute heart failure and STEMI.
Abstract:
The present study aimed to compare the serum level of uric acid in patients with and without heart failure and also to determine the association between uric acid level and clinical status by Killip class in patients with STEMI. This case-control study was conducted on 50 consecutives as control group and 50 patients with acute heart failure, (20 patients had acute STEMI), who documented by both clinical conditions and echocardiography assessment. The mean plasma level of uric acid in the case group was 7.6±1.6 milligrams/deciliter (mg/dL) and in the control group was 4.5±1.5 respectively (P<0.001). These values in patients with STEMI was about 9.2±0.86, but in patients with acute heart failure in absence of STEMI was 6.5±1.04 (P<0.001). Moreover, there was significant difference among the level of uric acid and Killip classes (P<0.001). Also there was significant difference for uric acid level between HFrEF (HF with reduced EF) and severe LV systolic dysfunction (0.049). In STEMI patients with culprit LAD, mean uric acid was significantly higher than cases with culprit LCX [(9.7±0.98 versus 8.6±0.52 respectively) P=0.012]. Regarding treatment plan in patients with STEMI, mean level of uric acid in those considered for CABG was significantly higher than who were considered for PCI, 9.9±0.82 versus 8.9±0.76 respectively, P=0.029. In STEMI patients with higher killip class, higher level of uric acid was seen. Also, the severity of LV systolic dysfunction was associated with higher level of uric acid.
More Related Videos
08:38Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery
Published on: August 16, 2019
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis III: Medical Management
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction
Acute Coronary Syndrome I: Introduction